Blood Cancer United booklet updates

We are committed to sharing with you the most up-to-date information about blood cancer treatment. See below for new treatments that have been FDA approved since our guides, fact sheets, and booklets were printed. 

For more information, contact an Information Specialist at (800) 955-4572 or [email protected].

Booklet titles by disease/topic

To access drug updates for the following booklet, click on the disease headings.

Leukemia

• Acute Lymphoblastic Leukemia (ALL ) in Adults (November 2024)
• Acute Lymphoblastic Leukemia (ALL) in Children and Teens (November 2024)
• The ALL Guide: Information for Patients and Caregivers (November 2024)
• Acute Myeloid Leukemia in Adults (November 2025)
• Acute Myeloid Leukemia in Children and Teens (November 2025)
• The AML Guide: Information for Patients and Caregivers (November 2025)
• ​Chronic Lymphocytic Leukemia​ (No updates)
• The CLL Guide: Information for Patients and Caregivers (No updates)
• Chronic Myeloid Leukemia​​ (No updates)
• The CML Guide: Information for Patients and Caregivers​ (No updates)

Lymphoma

• Cutaneous T-Cell Lymphoma (August 2024)
• Hodgkin Lymphoma: No updates
• Non-Hodgkin Lymphoma (November 2025)
• The Lymphoma Guide: Information for Patients and Caregivers (November 2025)

Myeloma

• Myeloma (November 2025)
• The Myeloma Guide: Information for Patients and Caregivers (November 2025)

​Myelodysplastic syndrome (MDS)

• ​​Myelodysplastic Syndromes  (June 2024)
• The MDS Guide: Information for Patients and Caregivers  (June 2024)

​Myeloproliferative neoplasms (MPNs)

• Myeloproliferative Neoplasms (No updates)

Treatment

• Blood and Marrow Stem Cell Transplantation (Updated December 2024)
• Blood and Marrow Stem Cell Transplantation Guide (Updated December 2024)
   

Other languages

Access Spanish-language booklet updates.